I think it really worth thinking of FBR as a biotech stock. They all need heavy investment and LOTS of patience. The key difference is that biotech can fall apart in a single clinical trial, FBR is very well positioned to reach mass adoption as they have proven the milestones already in testing. All it takes is that one big green light. We’ve seen it time and again that the market moves swiftly to balance sheet changes (and wider market awareness), once they have orders and flips to a positive balance sheet investors benefit.
- Forums
- ASX - By Stock
- Catalyst for re-rate
FBR
fbr ltd
Add to My Watchlist
16.7%
!
0.5¢

I think it really worth thinking of FBR as a biotech stock. They...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $28.44M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.5¢ | $42.71K | 7.682M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
166 | 85768214 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 5374411 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
158 | 83259603 | 0.005 |
35 | 14016265 | 0.004 |
21 | 11269665 | 0.003 |
9 | 11853000 | 0.002 |
15 | 50406023 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 5124411 | 13 |
0.007 | 15820757 | 28 |
0.008 | 3817731 | 11 |
0.009 | 2275330 | 4 |
0.010 | 1192625 | 5 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
FBR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online